Exact Mass: 164.1062

m-PEG3-OH

C7H16O4 (164.1049)

A hydroxypolyether that is the monomethyl ether derivative of triethylene glycol. Metabolite observed in cancer metabolism. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 5

1-Pyrimidinylpiperazine

C8H12N4 (164.1062)

1-Pyrimidinylpiperazine is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia) D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

Triethylene Glycol Monomethyl Ether

C7H16O4 (164.1049)

Triethylene Glycol Monomethyl Ether, also known as 3,6,9-Trioxa-1-decanol or Methoxytriethylene glycol, is classified as a member of the Polyethylene glycols. Polyethylene glycols are oligomers or polymers of ethylene oxide, with the general formula (C2H4O)n (with n>=3). Triethylene Glycol Monomethyl Ether is considered to be soluble (in water) and relatively neutral

1,1,3,3-Tetramethoxypropane

C7H16O4 (164.1049)

2,2'-Azobis(2-methylpropionitrile)

C8H12N4 (164.1062)

Tetra-methoxypropane

C7H16O4 (164.1049)

1-(2-Pyrimidyl)piperazine

C8H12N4 (164.1062)

Poloxalene

C7H16O4 (164.1049)

2-cyclopropyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine

C8H12N4 (164.1062)

Benzene, 1-fluoro-4-(1E)-1-pentenyl- (9CI)

C11H13F (164.1001)

Pyrido[3,4-b]pyrazin-3-amine, 5,6,7,8-tetrahydro-6-methyl- (9CI)

C8H12N4 (164.1062)

Pyrido[3,4-b]pyrazin-2-amine, 5,6,7,8-tetrahydro-6-methyl- (9CI)

C8H12N4 (164.1062)

DL-Lysine monohydrate

C6H16N2O3 (164.1161)

(2,4,5-TRIMETHYLPHENYL)BORONIC ACID

C9H13BO2 (164.1009)

4,4-DIFLUOROAMINOETHYLPIPERIDINE

C7H14F2N2 (164.1125)

(1-METHYLPIPERIDIN-4-YL)METHANAMINE DIHYDROCHLORIDE

C7H17ClN2 (164.108)

3-phenylpropylboronic acid

C9H13BO2 (164.1009)

3-Cyclopropyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine

C8H12N4 (164.1062)

PEG3

C7H16O4 (164.1049)

3-Piperazin-1-yl-pyridazine

C8H12N4 (164.1062)

Mesitylboronic acid

C9H13BO2 (164.1009)

2,2-Azobis(2-methylpropionitrile)

C8H12N4 (164.1062)

Benzyltrimethylsilane

C10H16Si (164.1021)

4-(Piperazin-1-yl)pyrimidine

C8H12N4 (164.1062)

N-[4-(Aminomethyl)phenyl]-guanidine

C8H12N4 (164.1062)

(Cyclohexylmethyl)hydrazine hydrochloride (1:1)

C7H17ClN2 (164.108)

(4-Propylphenyl)boronic acid

C9H13BO2 (164.1009)

5-AMINO-1-TERT-BUTYL-1H-PYRAZOLE-4-CARBONITRILE

C8H12N4 (164.1062)

L(+)-Lysine monohydrate

C6H16N2O3 (164.1161)

L-Lysine hydrate is an essential amino acid. L-Lysine hydrate can be research for vascular calcification (VC) and acute pancreatitis[1][2].

5-(1-Piperazinyl)pyrimidine

C8H12N4 (164.1062)

(S)-N,N-Dimethyl(pyrrolidin-2-yl)Methanamine HCl

C7H17ClN2 (164.108)

2-AMINO-3-PYRROLIDIN-1-YLPYRAZINE

C8H12N4 (164.1062)

dimethyl(2-phenylethyl)silicon

C10H16Si (164.1021)

2-[4-(cyanomethyl)piperazin-1-yl]acetonitrile

C8H12N4 (164.1062)

(3-Isopropylphenyl)boronic acid

C9H13BO2 (164.1009)

(2-Isopropylphenyl)boronic acid

C9H13BO2 (164.1009)

(2,2,6,6-2H4)Heptanedioic acid

C7H8D4O4 (164.0987)

Trans-N,N-dimethyl-1,2-cyclopentanediamine dihydrochloride

C7H17ClN2 (164.108)

2,7-DIMETHYL-5-SILASPIRO[4.4]NONA-2,7-DIENE

C10H16Si (164.1021)

1,1-Dimethoxy-2-(2-methoxyethoxy)ethane

C7H16O4 (164.1049)

3,3-Diethoxy-1,2-propanediol

C7H16O4 (164.1049)

BUTYLENE GLYCOL PROPIONATE

C7H16O4 (164.1049)

6-pyrrolidin-1-ylpyrimidin-4-amine

C8H12N4 (164.1062)

Piperazine, 2-ethyl-5-methyl-, hydrochloride

C7H17ClN2 (164.108)

Benzene,1-methyl-4-(trimethylsilyl)-

C10H16Si (164.1021)

1-CYCLOHEPTYLHYDRAZINE HYDROCHLORIDE

C7H17ClN2 (164.108)

4-Isopropylphenylboronic acid

C9H13BO2 (164.1009)

Kondensationsprodukte von mehrwertigen aliphatischen Alkoholen oder Kohlehydraten oder 1,2-Ethylendiamin mit Ethylenoxid und/oder Propylenoxid

C7H16O4 (164.1049)

1-(2-Pyrazinyl)piperazine

C8H12N4 (164.1062)

BIS(2-METHOXYETHOXY)METHANE

C7H16O4 (164.1049)

8-CHLORO-1-OCTANOL

C8H17ClO (164.0968)

Pluronic F-127

C7H16O4 (164.1049)

D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

S-propylamine-L-cysteine

C6H16N2OS (164.0983)

(3R)-2,2-dimethyl-3-methylphosphonoyloxybutane

C7H17O2P (164.0966)

1,3-Diamino-4,5,6-trihydroxy-cyclohexane

C6H16N2O3+2 (164.1161)

(S)-N-methylcathinone

C10H14NO+ (164.1075)

Aldehydo bacillosamine

C6H16N2O3+2 (164.1161)

Bacillosamine (pyranose form)

C6H16N2O3+2 (164.1161)

4-Deoxystreptamine

C6H16N2O3+2 (164.1161)

2,6-diamino-2,3,6-trideoxy-alpha-D-glucose(2+)

C6H16N2O3+2 (164.1161)

(R)-methcathinone(1+)

C10H14NO+ (164.1075)

2-(1-Piperazinyl)pyrimidine

C8H12N4 (164.1062)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

Pyrimidylpiperazine

C8H12N4 (164.1062)